Morgan Stanley Raises Ventas Price Target to $90 on 9% FFO Growth
Morgan Stanley raised Ventas’ price target to $90 from $80 and kept an Equal Weight rating, citing strong Q4 results, improving senior housing occupancy and potential acquisition opportunities ahead of March industry conferences. In 2025, normalized FFO per share rose 9%, same-store SHOP cash NOI climbed 15%, and total shareholder return reached 35%.
1. Price Target Raised to $90
On February 14, Morgan Stanley increased its Ventas price target to $90 from $80 while maintaining an Equal Weight rating, based on better-than-expected Q4 performance, an improving occupancy outlook in senior housing and potential acquisition opportunities. Analysts will seek updates on operating trends at early March industry conferences to validate occupancy gains and portfolio growth.
2. Strong 2025 Operating Performance
Ventas reported a 9% year-over-year increase in normalized FFO per share and a 15% rise in same-store SHOP cash NOI for 2025, driven by robust demand from an aging population and limited new supply in senior housing. The company delivered total shareholder returns of 35% in 2025, outpacing both the broader REIT sector and the S&P 500.
3. Senior Housing Growth Strategy
CEO Debra Cafaro highlighted the execution of the '1-2-3 Strategy' focused on senior housing as a long-term growth driver, noting favorable market conditions and strong operating results. Ventas’ diversified portfolio includes approximately 1,400 healthcare and senior living properties across North America and the UK, positioning it to capitalize on demographic tailwinds and potential acquisition deals.